Cost-Effective Prescribing in Elderly People
Health-Related Quality of Life Assessment and the Pharmaceutical Industry
Pharmacoeconomics of Antibacterial Treatment
Cost-Utility Analysis of Early Thrombolytic Therapy
Imipenem/Cilastatin
β-Blockers vs Calcium Channel Blockers vs ACE Inhibitors
Importance of Side Effects in Treating Impetigo
Should Indirect Costs and Benefits be Included?
Glossary of Terms Used in Pharmacoeconomic and Quality of Life Analyses